Skip to main content

August 2017, Vol 10, Special Issue: Payers’ Perspectives in Oncology: ASCO 2017 Highlights

Multiple Myeloma, Oncology
CAR T-Cell Immunotherapy Makes Strides in Multiple Myeloma, with Durable Remission
Wayne Kuznar
Read More
ASCO President Lists Progress Made in Cancer, Highlighting Current Priorities
Wayne Kuznar
Read More
Prostate Cancer
Abiraterone a Game-Changer in the Frontline Treatment of Metastatic Prostate Cancer
Wayne Kuznar
Read More
Immunotherapy, Oncology
Checkpoint Inhibitors Show Promise in Patients with Mesothelioma
Phoebe Starr
Read More
FDA Approvals
FDA News - August 2017
Read More
Immunotherapy, Oncology
Pembrolizumab Makes Inroads in Sarcoma Subtypes
Phoebe Starr
Read More
Leukemia, Oncology
In Chronic Myeloid Leukemia, Selection of Tyrosine Kinase Inhibitors Depends on Variables Other Than Survival
Wayne Kuznar
Read More
Leukemia, Oncology
ASCO 2017: Chronic Lymphocytic Leukemia Highlights
Read More
FDA Approvals
Novel Assay Provides 100 Times More Information Than Current Liquid Biopsies for Early Cancer Detection
Phoebe Starr
Read More
FDA Approvals
Cediranib-Based Combination Therapy Extends Progression-Free Survival in Relapsed Ovarian Cancer
Wayne Kuznar
Read More
Page 2 of 3
Results 11 - 20 of 27